NephTech is a medical technology company dedicated to provide patients and dialysis centres an evidence-based approach to vascular access surveillance and management. Vascular access is end stage renal disease (commonly known as kidney failure) patient’s lifeline, as it allows removal of body waste through hemodialysis, and without which patients do not survive beyond several days.

Among other innovations, the company is developing an economically feasible and revolutionary vascular access surveillance technology for dialysis centres to leapfrog quality of care and reduce cost inefficiencies through early prediction of vascular complications.

This, NephTech strongly believes, will address a vital unmet need to reduce the heavy financial expenditures in the hemodialysis space.

Our Vision



Improving a medically and financially crippling chronic diseases, specifically End Stage Renal Disease (ESRD) through innovation, through a ground up understanding of unmet needs and involvement of patients, renal nurses, dialysis centres, clinicians and hospitals in a user-centric design approach.









image

Dialysis Centres
image

End Stage RenalDisease
Patients
image

National Healthcare System
image

Government
image

Insurers

Testimonials